GlassScriptPhysician profile
Jaehoon Chung
NPI 1205138500
$6,893.50
in general payments reported to CMS, 2019-2025
50 companies · $1,424 in 2025
The $1,424 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,318 · 2020: $177 · 2021: $581 · 2022: $827 · 2023: $1,048 · 2024: $1,519 · 2025: $1,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,902 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,901.72 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,787.47 | 2019-2025 | Emblem Mri S-Icd, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $832.06 | 2019-2025 | Gallant, Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $643.21 | 2019-2025 | |
| Heartflow, INC. | $433.98 | 2022-2025 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $394.46 | 2019-2025 | Farxiga |
| Amgen INC. | $325.14 | 2020-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $252.28 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $229.97 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $223.70 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $207.90 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Abiomed | $143.65 | 2025 | |
| Medtronic, INC. | $142.32 | 2023-2025 | Minimed 780g |
| Regeneron Healthcare Solutions, INC. | $139.34 | 2019-2021 | |
| Esperion Therapeutics, INC. | $105.81 | 2023-2025 | Nexletol |
| Atricure, INC. | $73.55 | 2023-2024 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaehoon Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.